Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.
Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Oncogene. 2004 Feb 26;23(8):1539-48. doi: 10.1038/sj.onc.1207272. Oncogene. 2004. PMID: 14661056
RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance.
Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. Duxbury MS, et al. Clin Cancer Res. 2005 May 1;11(9):3433-8. doi: 10.1158/1078-0432.CCR-04-1510. Clin Cancer Res. 2005. PMID: 15867245 Free PMC article.
RNA interference: a mammalian SID-1 homologue enhances siRNA uptake and gene silencing efficacy in human cells.
Duxbury MS, Ashley SW, Whang EE. Duxbury MS, et al. Biochem Biophys Res Commun. 2005 Jun 3;331(2):459-63. doi: 10.1016/j.bbrc.2005.03.199. Biochem Biophys Res Commun. 2005. PMID: 15850781
Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.
Duxbury MS, Matros E, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Ann Surg. 2004 Oct;240(4):667-74; discussion 675-6. doi: 10.1097/01.sla.0000140755.97224.9a. Ann Surg. 2004. PMID: 15383794 Free PMC article.
Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer.
Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Surgery. 2004 Aug;136(2):261-9. doi: 10.1016/j.surg.2004.04.029. Surgery. 2004. PMID: 15300189
Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness.
Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Biochem Biophys Res Commun. 2004 Aug 6;320(4):1096-102. doi: 10.1016/j.bbrc.2004.06.054. Biochem Biophys Res Commun. 2004. PMID: 15249202
Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness.
Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Oncogene. 2004 Jul 29;23(34):5834-42. doi: 10.1038/sj.onc.1207775. Oncogene. 2004. PMID: 15208677
siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity.
Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. J Am Coll Surg. 2004 Jun;198(6):953-9. doi: 10.1016/j.jamcollsurg.2004.01.037. J Am Coll Surg. 2004. PMID: 15194078
A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. Duxbury MS, et al. Cancer Res. 2004 Jun 1;64(11):3987-93. doi: 10.1158/0008-5472.CAN-04-0424. Cancer Res. 2004. PMID: 15173012
CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma.
Duxbury MS, Ito H, Ashley SW, Whang EE. Duxbury MS, et al. Biochem Biophys Res Commun. 2004 May 7;317(3):837-43. doi: 10.1016/j.bbrc.2004.03.128. Biochem Biophys Res Commun. 2004. PMID: 15081416
34 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback